Al Robichaud
Private Equity Investor presso Cure Ventures Management LP
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Attualmente, Albert J. Robichaud è direttore scientifico di SAGE Therapeutics, Inc. Robichaud ha precedentemente ricoperto la posizione di VP-Chemistry & Pharmacokinetic Sciences presso Lundbeck USA Inc., VP-Chemistry & Pharmacokinetic Sciences presso Lundbeck, Inc. e Senior Director & Head-Neuroscience Discovery presso Wyeth Research. Albert J. Robichaud ha conseguito una laurea presso il Rensselaer Polytechnic Institute e un dottorato presso la University of California, Irvine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.24% | 13/02/2023 | 145 553 ( 0.24% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Al Robichaud
| Società | Posizione | Inizio |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/01/2024 |
Precedenti posizioni note di Al Robichaud
| Società | Posizione | Fine |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09/10/2023 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Corporate Officer/Principal | 01/01/2011 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Director/Board Member | 01/01/2010 |
| Lundbeck USA Inc. | Corporate Officer/Principal | - |
Formazione di Al Robichaud
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Health Technology |
| Lundbeck USA Inc. | |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Al Robichaud
